Intravenous Injection of MVA Virus Targets CD8+ Lymphocytes to Tumors to Control Tumor Growth upon Combinatorial Treatment with a TLR9 Agonist
Fend, L., Gatard-Scheikl, T., Kintz, J., Gantzer, M., Schaedler, E., Rittner, K., Cochin, S., Fournel, S., Preville, X.Volume:
2
Language:
english
Journal:
Cancer Immunology Research
DOI:
10.1158/2326-6066.CIR-14-0050
Date:
December, 2014
File:
PDF, 1.63 MB
english, 2014